NCS-01

N/A

Report date: 2023/01/12 15:28:35

Base Information

Drug NameNCS-01

Drug Alias NameNCS-01

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemic Stroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNc Medial Research Inc

China Registration ClassN/A

Develop Information

Active CompaniesNc Medial Research Inc

Inactive CompaniesN/A

Active IndicationsIschemic Stroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A